Cohen C
Arch Dermatol. 1980 Jun;116(6):687-9.
There is an increased risk of malignancy (particularly skin carcinomas and malignant lymphomas) in patients who have genetically determined and acquired immunosuppression. Multiple cutaneous squamous and basal cell carcinomas of the face and scalp with adjacent lymphomatous infiltration of the skin developed in a patient with stage IVA diffuse poorly differentiated lymphocytic lymphoma. He had had one cycle of vincristine sulfate, prednisone, and cyclophosphamide therapy for his lymphoma more than one year before. He showed impaired delayed hypersensitivity response on skin testing with common antigens and he had a low serum (IgG) level.
在具有遗传性和获得性免疫抑制的患者中,发生恶性肿瘤(尤其是皮肤癌和恶性淋巴瘤)的风险增加。一名患有IVA期弥漫性低分化淋巴细胞淋巴瘤的患者,面部和头皮出现多发性皮肤鳞状和基底细胞癌,并伴有相邻皮肤的淋巴瘤浸润。一年多前,他曾接受过一个周期的硫酸长春新碱、泼尼松和环磷酰胺治疗淋巴瘤。他对常见抗原的皮肤试验显示迟发型超敏反应受损,血清(IgG)水平较低。